Invesco’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $193M | Sell |
|
|||||
|
2021
Q1 | $174M | Sell |
|
|||||
|
2020
Q4 | $179M | Buy |
|
|||||
|
2020
Q3 | $120M | Buy |
|
|||||
|
2020
Q2 | $110M | Sell |
|
|||||
|
2020
Q1 | $109M | Sell |
|
|||||
|
2019
Q4 | $170M | Sell |
|
|||||
|
2019
Q3 | $337M | Buy |
|
|||||
|
2019
Q2 | $430M | Sell |
|
|||||
|
2019
Q1 | $502M | Buy |
|
|||||
|
2018
Q4 | $358M | Sell |
|
|||||
|
2018
Q3 | $565M | Sell |
|
|||||
|
2018
Q2 | $533M | Buy |
|
|||||
|
2018
Q1 | $433M | Sell |
|
|||||
|
2017
Q4 | $493M | Sell |
|
|||||
|
2017
Q3 | $662M | Buy |
|
|||||
|
2017
Q2 | $536M | Buy |
|
|||||
|
2017
Q1 | $448M | Sell |
|
|||||
|
2016
Q4 | $453M | Buy |
|
|||||
|
2016
Q3 | $379M | Buy |
|
|||||
|
2016
Q2 | $281M | Sell |
|
|||||
|
2016
Q1 | $394M | Sell |
|
|||||
|
2015
Q4 | $609M | Sell |
|
|||||
|
2015
Q3 | $505M | Buy |
|
|||||
|
2015
Q2 | $535M | Buy |
|
|||||
|
2015
Q1 | $460M | Sell |
|
|||||
|
2014
Q4 | $580M | Sell |
|
|||||
|
2014
Q3 | $555M | Sell |
|
|||||
|
2014
Q2 | $589M | Sell |
|
|||||
|
2014
Q1 | $632M | Buy |
|
|||||
|
2013
Q4 | $471M | Buy |
|
|||||
|
2013
Q3 | $360M | Buy |
|
|||||
|
2013
Q2 | $213M | Buy |
|